JOHNSON & JOHNSON — Director's Dealing 2025

Feb 19, 2025

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: JOHNSON & JOHNSON (JNJ)
CIK: 0000200406
Period of Report: 2025-02-13

Reporting Person: Schmid Timothy (EVP, WW Chair, MedTech)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2025-02-13	Common Stock	M	499	—	Acquired	13539	Direct
2025-02-14	Common Stock	F	193	$155.26	Disposed	13346	Direct
2025-02-14	Common Stock	M	1765	—	Acquired	15111	Direct
2025-02-14	Common Stock	F	639	$156.71	Disposed	14472	Direct
2025-02-15	Common Stock	M	1029	—	Acquired	15501	Direct
2025-02-18	Common Stock	S	403	$156.15	Disposed	15098	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2025-02-13	Restricted Share Units	$	M	499	Disposed		Common Stock (499)	Direct
2025-02-14	Restricted Share Units	$	M	1765	Disposed		Common Stock (1765)	Direct
2025-02-15	Restricted Share Units	$	M	1029	Disposed		Common Stock (1029)	Direct

Footnotes

F1: Awarded under Issuer's Long-Term Incentive Plan. The Restricted Share Units (RSUs) awarded on February 13, 2023 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSUs convert into shares of Common Stock upon vesting.

F2: Shares withheld for payment of taxes upon vesting of RSUs.

F3: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 14, 2022 vest three years after date of grant. The RSUs convert into shares of Common Stock upon vesting.

F4: Awarded under Issuer's Long-Term Incentive Plan. The RSUs awarded on February 15, 2024 vest in three annual equal installments beginning on the first anniversary of the grant date. The RSU convert into shares of Common Stock upon vesting.

F5: Each RSU represents a contingent right to receive one share of Company Common Stock.